Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric electroencephalogram study

Annals of Neurology

Volumn 59, Issue 2, 2006, Pages 323-334

  Babiloni, Claudio ^a,b   Benussi, Luisa ^b   Binetti, Giuliano ^b   Cassetta, Emanuele ^b   Dal Forno, Gloria ^e   Del Percio, Claudio ^a,b   Ferreri, Florinda ^c,d,e   Ferri, Raffaele ^f   Frisoni, Giovanni ^b,c,d   Ghidoni, Roberta ^b   Miniussi, Carlo ^b   Rodriguez, Guido ^g   Romani, Gian Luca ^h   Squitti, Rosanna ^c,d   Ventriglia, Maria Carla ^c,d   Rossini, Paolo M ^b,c,d,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c Ospedele Fatebenefratelli

^d Osp FBF Isola Tiberina   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f OASI RESEARCH INSTITUTE IRCCS   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALPHA RHYTHM; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL;

AGED; ALLELES; ALPHA RHYTHM; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; GENOTYPE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 32044447923     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20724     Document Type: Article

References (139)

1. Flicker CS, Ferris H, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006-1009.
2. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
3. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
4. Galluzzi S, Cimaschi L, Ferrucci L, Frisoni GB. Mild cognitive impairment: clinical features and review of screening instruments. Aging 2001;13:183-202.
5. Scheltens P, Fox N, Barkhof F, De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002;1:13-21.
6. Arnaiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand 2003;107:34-41.
7. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population. The Framingham Study. Neurology 1993;43:515-519.
8. Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer's disease. A meta-analysis. Arch Gen Psychiatry 1998;55:809-815.
9. Frisoni GB, Padovani A, Wahlund LO. The predementia diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord 2004;18:51-53.
10. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
11. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
12. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-1371.
13. Dierks T, Ihl R, Frolich L, Maurer K. Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatry Res 1993;50:51-162.
14. Dierks T, Jelic V, Pascual-Marqui RD, et al. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol 2000;111:1817-1824.
15. Huang C, Wahlund LO, Dierks T, et al. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol 2000;11:1961-1967.
16. Ponomareva NV, Selesneva ND, Jarikov GA. EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 2003;48:152-159.
17. Babiloni C, Binetti G, Cassetta E, et al. Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multi-centric EEG study. NeuroImage 2004;22:57-67.
18. Zappoli R, Versari A, Paganini M, et al. Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia. Ital J Neurol Sci 1995;16:341-376.
19. Jelic V, Shigeta M, Julin P. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 1996;7:314-323.
20. Grunwald M, Busse F, Hensel A, Kruggel F, et al. Links correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia. J Clin Neurophysiol 2001;18:178-184.
21. Grunwald M, Busse F, Hensel A, et al. Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks. Alzheimer Dis Assoc Disord 2002;16:40-48.
22. Frodl T, Hampel H, Juckel G, et al. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's disease. Psychophysiology 2002;39:175-181.
23. Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. Dement Geriatr Cogn Disord 1997;8:180-187.
24. Jelic V, Johansson SE, Almkvist O, et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 2000;21:533-540.
25. Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci 2004;23:225-233.
26. Bunce D, Fratiglioni L, Small BJ, et al. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 2004;63:816-821.
27. Chou CY, Lin YL, Huang YC, et al. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. Biophys J 2004;88:455-466.
28. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
29. Corder EH, Saunders AM, Pericak-Vance MA, Roses AD. There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease. Arch Neurol 1995;52:650-651.
30. Crutcher KA. Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease. J Mol Neurosci 2004;23:81-88.
31. Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 2004;23:189-204.
32. Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 2004;25:651-660.
33. Qiu C, Kivipelto M, Aguero-Torres H, et al. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry 2004;75:828-833.
34. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset alzheimer's disease. Neurology 1993;43:1467-1472.
35. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
36. Rebeck GW, Kindy M, LaDu MJ. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis 2002;4:145-154.
37. Dal Forno G, Carson KA, Brookmeyer R, et al. APOE genotype and survival in men and women with Alzheimer's disease. Neurology 2002;58:1045-1050.
38. Bartres-Faz D, Junque C, Lopez-Alomar A, et al. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J Am Geriatr Soc 2001;49:985-990.
39. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein e4 allele and cognitive decline in elderly men. Br Med J 1994;309:1202-1206.
40. Caselli RJ, Reiman EM, Osborne D, et al. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004;62:1990-1995.
41. Small GW, La Rue A, Komo S, et al. Predictors of cognitive change in middle-aged and older adults with memory loss. Am J Psychiatry 1995;152:1757-1764.
42. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4-allele for apolipoprotein E. N Engl J Med 1996;334:752-758.
43. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-456.
44. Lee KU, Lee JS, Kim KW, et al. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients. J Neuropsychiatry Clin Neurosci 2003;15:78-83.
45. Mosconi L, Nacmias B, Sorbi S, et al. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:370-376.
46. Scarmeas N, Anderson KE, Hilton J, et al. APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology 2004;63:913-915.
47. Small GW. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. J Clin Psychiatry 1996;57:9-13.
48. Small GW, Komo S, La Rue A, et al. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann NY Acad Sci 1996;802:70-78.
49. Jelic V, Julin P, Shigeta M, et al. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry 1997;63:59-65.
50. Lehtovirta M, Partanen J, Kononen M. Spectral analysis in Alzheimer's disease: relation to apolipoprotein E polymorphism. Eur J Neurol 1995;2:129-d130.
51. Lehtovirta M, Partanen J, Kononen M, et al. Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurobiol Aging 1996;17:523-526.
52. Lehtovirta M, Partanen J, Kononen M, et al. A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism. Dement Geriatr Cogn Disord 2000;11:29-35.
53. Babiloni C, Binetti G, Cassarino A, et al. Sources of cortical rhythms in adults during physiological aging: a multi-centric EEG study. Hum Brain Mapping 2005 [Epub ahead of print].
54. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
55. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiat Res 1975;12:189-198.
56. Hughes CP, Berg L, Danziger WL, et al. A new clinical rating scale for the staging of dementia. Br J Psychiatry 1982;140:1225-1230.
57. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-83;17:37-49.
58. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
59. Lawton MP, Brodie EM. Assessment of older people: self maintaining and instrumental activity of daily living. J Gerontol 1969;9:179-186.
60. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 1989;46:379-382.
61. Albert M, Smith LA, Scherr PA, et al. Use of brief cognitive test to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
62. Zaudig M. A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr 1992;4:203-219.
63. Devanand DP, Folz M, Gorlyn M, et al. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997;45:321-328.
64. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9:65-69.
65. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
66. Buchan RJ, Nagata K, Yokoyama JE, Langman, et al. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroencephalogr Clin Neurophysiol 1997;103:409-417.
67. Muller TJ, Thome J, Chiaramonti R, et al. A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1997;247:259-263.
68. Pucci E, Belardinelli N, Cacchio G, et al. EEG power spectrum differences in early and late onset forms of Alzheimer's disease. Clin Neurophysiol 1999;110:621-631.
69. Szelies B, Mielke R, Kessler J, Heiss WD. EEG power changes are related to regional cerebral glucose metabolism in vascular dementia. Clin Neurophysiol 1999;110:615-620.
70. Rodriguez G, Vitali P, De Leo C, et al. Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology 2002;46:49-56.
71. Babiloni C, Ferri R, Moretti DV, et al. Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study. Eur J Neurosci 2004;19:2583-2590.
72. Moretti DV, Babiloni F, Carducci F, et al. Computerized processing of EEG-EOG-EMG artifacts for multicentirc studies in EEG oscillations and event-related potentials. Int J Pshycophysiol 2003;47:199-216.
73. Leuchter AF, Cook IA, Newton TF, et al. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroenceph Clin Neurophysiol 1993;87:385-393.
74. Besthorn C, Zerfass R, Geiger-Kabisch C, et al. Discrimination of Alzheimer's disease and normal aging by EEG data. Electroencephalogr Clin Neurophysiol 1997;103:241-248.
75. Chiaramonti R, Muscas GC, Paganini M, et al. Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type. Neuropsychobiology 1997;36:153-158.
76. Rodriguez G, Copello F, Nobili F, et al. EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol 1999;110:1831-1837.
77. Rodriguez G, Nobili F, Copello F, et al. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. J Nucl Med 1999;40:522-529.
78. Cook IA, Leuchter AF. Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG. Behav Brain Res 1996;78:15-23.
79. Holschneider DP, Waite JJ, Leuchter AF, et al. Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin. Exp Brain Res 1999;126:270-280.
80. Klimesch W. Memory processes, brain oscillations and EEG synchronization. Int J Psychophysiol 1996;24:61-100.
81. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Rev 1999;29:169-195.
82. Nobili F, Taddei G, Vitali P, et al. Relationships between 99m Tc-HMPAO ceraspect and quantitative EEG observations in Alzheimer's disease. Arch Gerontol Geriatr 1998;6:363-368.
83. Pucci E, Cacchiò G, Angeloni R, et al. EEG spectral analysis in Alzheimer's disease and different degenerative dementias. Arch Gereontol Geriatr 1997;26:283-297
84. Kolev V, Yordanova J, Basar-Eroglu C, Basar E. Age effects on visual EEG responses reveal distinct frontal alpha networks. Clin Neurophysiol 2002;113:901-910.
85. Klimesch W, Doppelmayr M, Pachinger T, Russegger H. Event-related desynchronization in the alpha band and the processing of semantic information. Brain Res Cogn Brain Res 1997;6:83-94.
86. Klimesch W, Doppelmayr M, Russegger H, et al. Induced alpha band power changes in the human EEG and attention. Neurosci Lett 1998;244:73-76.
87. Babiloni C, Babiloni F, Carducci F, et al. Human alpha rhythms during visual delayed choice reaction time tasks. A MEG study. Hum Brain Mapping 2004;24:184-192.
88. Babiloni C, Babiloni F, Carducci F, et al. Human cortical rhythms during visual delayed choice reaction time tasks. A high-resolution EEG study on normal aging. Behav Brain Res 2004;153:261-271.
89. Babiloni C, Miniussi C, Babiloni F, et al. Sub-second "temporal attention" modulates alpha rhythms. A high-resolution EEG study. Cogn Brain Res 2004;19:259-268.
90. Babiloni C, Babiloni F, Carducci F, et al. Human cortical responses during one-bit short-term memory: a high-resolution EEG study on delayed choice reaction time tasks. Clin Neurophysiol 2004;115:161-170.
91. Babiloni C, Babiloni F, Carducci F, et al. Human cortical EEG rhythms during long-term episodic memory task: a high resolution EEG study of the HERA model. Neuroimage 2004;21:1576-1584.
92. Pascual-Marqui RD, Michel CM, Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 1994;18:49-65.
93. Pascual-Marqui RD, Lehmann D, Koenig T, et al. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 1999;90:169-179.
94. Pascual-Marqui RD, Esslen M, Kochi K, Lehmann D. Functional imaging with low resolution brain electromagnetic tomography (LORETA): a review. Methods Find Exp Clin Pharmacol 2002;24:91-95.
95. Yao D, He B. A self-coherence enhancement algorithm and its application to enhancing three-dimensional source estimation from EEGs. Ann Biomed Eng 1997;29:1019-1027.
96. Phillips C, Rugg MD, Friston KJ. Systemic regularization of linear inverse solutions of the EEG source localization problem. Neuroimage 2002;17:287-301.
97. Mulert C, Pogarell O, Juckel G, et al. The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators. Eur Arch Psychiatry Clin Neurosci 2004;254:190-198.
98. Oakes TR, Pizzagalli DA, Hendrick AM, et al. Functional coupling of simultaneous electrical and metabolic activity in the human brain. Hum Brain Mapp 2004;21:257-270.
99. Mulert C, Jager L, Schmitt R, et al. Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage 2004;22:83-94.
100. Mulert C, Jager L, Propp S, et al. Sound level dependence of the primary auditory cortex: simultaneous measurement with 61-channel EEG and fMRI. Neuroimage 2005;28:49-58.
101. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme, 1988.
102. Anderer P, Saletu B, Pascual-Marqui RD. Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res 2000;100:81-96.
103. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. Non-invasive localization of P300 sources in normal aging and age-associated memory impairment. Neurobiol Aging 2003;24:463-479.
104. Anderer P, Saletu B, Saletu-Zyhlarz G, et al. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology 2004;49:134-153.
105. Isotani T, Lehmann D, Pascual-Marqui RD, et al. EEG source localization and global dimensional complexity in high- and low-hypnotizable subjects: a pilot study. Neuropsychobiology 2001;44:192-198.
106. Kawasaki T, Tanaka S, Wang J, et al. Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry Clin Neurosci 2004;58:68-75.
107. Mulert C, Gallinat J, Pascual-Marqui R, et al. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 2001;13:589-600.
108. Winterer G, Mulert C, Mientus S, et al. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 2001;13:299-313
109. Laufer I, Pratt H. Evoked potentials to auditory movement sensation in duplex perception. Clin Neurophysiol 2003;114:1316-1331.
110. Laufer I, Pratt H. The electrophysiological net response ("F-complex") to spatial fusion of speech elements forming an auditory object. Clin Neurophysiol 2003;114:818-834.
111. Cincotti F, Babiloni C, Miniussi C, et al. EEG deblurring techniques in a clinical context. Methods. Inf Med 2004;43:114-117.
112. Veiga H, Deslandes A, Cagy M, et al. Neurocortical electrical activity tomography in chronic schizophrenics. Arq Neuropsiquiatr 2003;61:712-717.
113. Nuwer MR. Quantitative EEG. I: techniques and problems of frequency analysis and topographic mapping. J Clin Neurophysiol 1988;5:1-43.
114. Hernández JL, Valdés P, Biscay R, et al. A global scale factor in brain topography. Int J Neurosci 1994;76:267-278.
115. Cook DG, Leverenz JB, McMillan PJ, et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 2003;162:313-319.
116. Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 2004;29:427-441.
117. Steriade M, Llinas RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988;68:649-742.
118. Brunia CH. Neural aspects of anticipatory behavior. Acta Psychol (Amst) 1999;101:213-242.
119. Pfurtscheller G, Lopez da Silva F. Event-related EEG/MEG synchronization and desynchronization: basic principles. Clin Neurophysiol 1999;110:1842-1857.
120. Buser P. Thalamocortical mechanisms underlying synchronised EEG activity. A textbook of clinical neurophysiology: (Halliday AM, Butler SR, Paul R, eds), pp 595-621. Chichester, UK: Wiley, 1987.
121. Rossini PM, Desiato MT, Lavaroni F, Caramia MD. Brain excitability and electroencephalographic activation: non-invasive evaluation in healthy humans via transcranial magnetic stimulation. Brain Res 1991;567:111-119.
122. Ricceri L, Minghetti L, Moles A, et al. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp Neurol 2004;189:162-172
123. Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Brain Res Rev 1997;23:28-46.
124. Sarter M, Bruno JP. Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable. Brain Res Brain Res Rev 1998;27:143-156.
125. Kobayashi Y, Tadashi I. Sensory-motor gating and cognitive control by the brainstem cholinergic system. Neural Networks 2002:731-741.
126. Muzur A, Pace-Schott EF, Hobson JA. The prefrontal cortex in sleep. Trends Cogn Sci 2002;6:475-481.
127. Babiloni C, Babiloni F, Carducci F, et al. Movement-related electroencephalographic reactivity in Alzheimer disease. Neuroimage 2000;12:139-146.
128. Babiloni C, Cassetta E, Chiovenda P, et al. Frontomedial alpha hyper-reactivity in mild demented patients during visual delayed response tasks. A MEG study. Brain Res Bull 2005;65:457-470.
129. Alagona G, Bella R, Ferri R, et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett 2001;314:57-60.
130. Ferri R, Del Gracco S, Elia M, et al. Scalp topographic mapping of middle-latency somatosensory evoked potentials in normal aging and dementia. Neurophysiol Clin 1996;26:311-319.
131. Ferreri F, Pauri F, Pasqualetti P, et al. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann Neurol 2003;53:102-108.
132. Pennisi G, Alagona G, Ferri R, et al. Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci Lett 2002;329:293-296.
133. Holschneider DP, Leuchter AF, Scremin OU, et al. Effects of cholinergic deafferentation and NGF on brain electrical coherence. Brain Res Bull 1998;45:531-541.
134. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learning Memory 2004:1143-1149.
135. Mesulam M, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 2004;55:815-828.
136. Mash DC, Flynn DD, Potter LT. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 1985;228:1115-1117.
137. Geula C, Mesulam MM. Cortical cholinerigc fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 1989;33:469-481.
138. Geula C, Mesulam MM. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb Cortex 1996;6:165-177.
139. Geula C, Mesulam MM. Cholinergic system in Alzheimer's disease. 2nd ed. In: Alzheimer disease, Terry RD, et al., eds. Philadelphia: Lippincott, 1999.